menu

Targeting the DNA Damage Response: Updates from the 2021 SABCS

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Targeting the DNA Damage Response: Updates from the 2021 SABCS

ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Sponsored by

  • Overview

    As DNA damage response therapies move beyond PARP inhibitors, what do we need to know? Dr. Timothy Yap from the University of Texas MD Anderson Cancer Center shares insights and takeaways from his presentation at the 2021 San Antonio Breast Cancer Symposium.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Sponsored by

  • Overview

    As DNA damage response therapies move beyond PARP inhibitors, what do we need to know? Dr. Timothy Yap from the University of Texas MD Anderson Cancer Center shares insights and takeaways from his presentation at the 2021 San Antonio Breast Cancer Symposium.

Facebook Comments

Schedule29 Jan 2022
Webpack App